EUVIMEDEUVIMED entdecken
Crossref

Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics

Aleix Rius Rigau iD, Yi-Nan Li iD, Alexandru-Emil Matei iD, Andrea-Hermina Györfi iD, Peter-Martin Bruch iD, Sarah Koziel iD, Veda Devakumar iD, Armando Gabrielli iD, Alexander Kreuter, Jiucun Wang iD, Sascha Dietrich, Georg Schett und 2 weitere

Circulation Research · 2024

DOI: 10.1161/circresaha.123.323299 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation Research, 2024. Verfasst von Aleix Rius Rigau und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine 3, Rheumatology and Clinical Immunology (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnb…. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Endothelial Progenitor Cells. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 53 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Systemic sclerosis (SSc) is a connective tissue disease that can serve as a model to study vascular changes in response to inflammation, autoimmunity, and fibrotic remodeling. Although microvascular changes are the earliest histopathologic manifestation of SSc, the vascular pathophysiology remains poorly understood. METHODS: We applied spatial proteomic approaches to deconvolute the heterogeneity of vascular cells at the single-cell level in situ and characterize cellular alterations of the vascular niches of patients with SSc. Skin biopsies of patients with SSc and control individuals were analyzed by imaging mass cytometry, yielding a total of 90 755 cells including 2987 endothelial cells and 4096 immune cells. RESULTS: We identified 7 different subpopulations of blood vascular endothelial cells (VECs), 2 subpopulations of lymphatic endothelial cells, and 3 subpopulations of pericytes. A novel population of CD34 + ;αSMA + (α-smooth muscle actin);CD31 + VECs was more common in SSc, whereas endothelial precursor cells were decreased. Co-detection by indexing and tyramide signal amplification confirmed these findings. The microenvironment of CD34 + ;αSMA + ;CD31 + VECs was enriched for immune cells and myofibroblasts, and CD34 + ;αSMA + ;CD31 + VECs expressed markers of endothelial-to-mesenchymal transition. The density of CD34 + ;αSMA + ;CD31 + VECs was associated with clinical progression of fibrosis in SSc. CONCLUSIONS: Using spatial proteomics, we unraveled the heterogeneity of vascular cells in control individuals and patients with SSc. We identified CD34 + ;αSMA + ;CD31 + VECs as a novel endothelial cell population that is increased in patients with SSc, expresses markers for endothelial-to-mesenchymal transition, and is located in close proximity to immune cells and myofibroblasts. CD34 + ;αSMA + ;CD31 + VEC counts were associated with clinical outcomes of progressive fibrotic remodeling, thus providing a novel cellular correlate for the crosstalk of vasculopathy and fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicEndothelial Progenitor CellsHumansProteomicsFibrosisMyofibroblasts

Stichwörter der Autor:innen

endothelial cellsfibrosisproteomicsscleroderma, systemicvascular system injuries

Autor:innen und Institutionen

  • Department of Internal Medicine 3, Rheumatology and Clinical Immunology (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, Germany.
  • Deutsches Zentrum Immuntherapie (A.R.R., G.S., J.H.W.D., M.L.), Friedrich-Alexander-University Erlangen-Nürnberg and University Hospital Erlangen, Germany.
  • Clinic for Rheumatology (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.
  • Hiller Research Center (Y.-N.L., A.-E.M., A.-H.G., V.D., A.G., J.H.W.D., M.L.), University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University, Germany.
  • Department of Haematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Germany (P.-M.B., S.K., S.D.).
  • Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf, Aachen Bonn Cologne, Germany (P.-M.B., S.K., S.D.).

ORCID-Profile: Aleix Rius Rigau, Yi-Nan Li, Alexandru-Emil Matei, Andrea-Hermina Györfi, Peter-Martin Bruch, Sarah Koziel, Veda Devakumar, Armando Gabrielli, Jiucun Wang, Jörg H W Distler, Minrui Liang

Zitieren

APA

Rius Rigau, A., Li, Y. N., Matei, A. E., Györfi, A. H., Bruch, P. M., Koziel, S., Devakumar, V., Gabrielli, A., Kreuter, A., Wang, J., Dietrich, S., Schett, G., Distler, J. H. W., & Liang, M. (2024). Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics. Circulation Research. https://doi.org/10.1161/circresaha.123.323299

Vancouver

Rius Rigau A, Li YN, Matei AE, Györfi AH, Bruch PM, Koziel S, et al. Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics. Circulation Research. 2024. doi:10.1161/circresaha.123.323299

BibTeX
@article{RiusRigau2024,
  author = {Rius Rigau, Aleix and Li, Yi-Nan and Matei, Alexandru-Emil and Györfi, Andrea-Hermina and Bruch, Peter-Martin and Koziel, Sarah and Devakumar, Veda and Gabrielli, Armando and Kreuter, Alexander and Wang, Jiucun and Dietrich, Sascha and Schett, Georg and Distler, Jörg H W and Liang, Minrui},
  title = {Characterization of Vascular Niche in Systemic Sclerosis by Spatial Proteomics},
  journal = {Circulation Research},
  year = {2024},
  doi = {10.1161/circresaha.123.323299}
}
Kostenlos starten →